Baek SJ, Lee DW, Park SS, Kim SH. Current status of robot-assisted gastric surgery. World J Gastrointest Oncol 2011; 3(10): 137-143
Corresponding Author of This Article
Sung-Soo Park, MD, PhD, Division of Upper GI Surgery, Department of Surgery, Korea University College of Medicine, MIS and Robotic Surgery Center, Korea University Medical Center, Korea University Anam Hospital, Anam-dong 5-ga Seongbuk-gu, Seoul 136-705, South Korea. email@example.com
Article-Type of This Article
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
World J Gastrointest Oncol. Oct 15, 2011; 3(10): 137-143 Published online Oct 15, 2011. doi: 10.4251/wjgo.v3.i10.137
Current status of robot-assisted gastric surgery
Se-Jin Baek, Dong-Woo Lee, Sung-Soo Park, Seon-Hahn Kim
Se-Jin Baek, Dong-Woo Lee, Department of Surgery, Korea University College of Medicine, MIS and Robotic Surgery Center, Korea University Medical Center, Korea University Anam Hospital, Seoul 136-705, South Korea
Sung-Soo Park, Division of Upper GI Surgery, Department of Surgery, Korea University College of Medicine, MIS and Robotic Surgery Center, Korea University Medical Center, Korea University Anam Hospital, Seoul 136-705, South Korea
Seon-Hahn Kim, Division of Colorectal, Department of Surgery, Korea University College of Medicine, MIS and Robotic Surgery Center, Korea University Medical Center, Korea University Anam Hospital, Seoul 136-705, South Korea
ORCID number: $[AuthorORCIDs]
Author contributions: Baek SJ and Park SS mainly contributed to this paper; Lee DW edited the data; Kim SH reviewed generally.
Supported by A grant from the National R&D Program for Cancer Control, Ministry of Health and Welfare, Republic of Korea (1020410)
Correspondence to: Sung-Soo Park, MD, PhD, Division of Upper GI Surgery, Department of Surgery, Korea University College of Medicine, MIS and Robotic Surgery Center, Korea University Medical Center, Korea University Anam Hospital, Anam-dong 5-ga Seongbuk-gu, Seoul 136-705, South Korea. firstname.lastname@example.org
Telephone: +82-2-9206772 Fax: +82-2-9281631
Received: November 23, 2010 Revised: October 4, 2011 Accepted: October 10, 2011 Published online: October 15, 2011
In an effort to minimize the limitations of laparoscopy, a robotic surgery system was introduced, but its role for gastric cancer is still unclear. The objective of this article is to assess the current status of robotic surgery for gastric cancer and to predict future prospects. Although the current study was limited by its small number of patients and retrospective nature, robot-assisted gastrectomy with lymphadenectomy for the treatment of gastric cancer is a feasible and safe procedure for experienced laparoscopic surgeons. Most studies have reported satisfactory results for postoperative short-term coutcomes, such as: postoperative oral feeding, gas out, hospital stay and complications, compared with laparoscopic surgery; the difference is a longer operation time. However, robotic surgery showed a shallow learning curve compared with the familarity of conventional open surgery; after the accumulation of several cases, robotic surgery could be expected to result in a similar operation time. Robotic-assisted gastrectomy can expand the indications of minimally invasive surgery to include advanced gastric cancer by improving the ability to perform lymphadenectomy. Moreover, ”total” robotic gastrectomy can be facilitated using a robot-sewing technique and gastric submucosal tumors near the gastroesophageal junction or pylorus can be resected safely by this novel technique. In conclusion, robot-assisted gastrectomy may offer a good alternative to conventional open or laparoscopic surgery for gastric cancer, provided that long-term oncologic outcomes can be confirmed.
Citation: Baek SJ, Lee DW, Park SS, Kim SH. Current status of robot-assisted gastric surgery. World J Gastrointest Oncol 2011; 3(10): 137-143
Since its introduction in the 1980s, laparoscopic surgery has become widely accepted and used as a minimally invasive approach for a number of procedures because it offers a number of patient benefits compared to open surgery such as milder morbidity, earlier time to walking, flatus, and oral intake, and quicker recovery with a shorter hospital stay[2-5]. In the field of gastric cancer, laparoscopic gastrectomy has been rapidly adopted, especially in Korea and Japan[6-11]. Although patients benefit from laparoscopic surgery, its ergonomic discomfort and counterintuitive instruments hinder the application of laparoscopic surgery for more advanced procedures; this procedure is also more stressful for surgeons than open surgery.
In an effort to minimize the difficulty of laparoscopy, a robotic surgery system was introduced[12,13]. The da Vinci Surgical System (Intuitive Surgical Inc., Sunnyvale, CA, USA) aimed to relieve the shortcomings of laparoscopic surgery by maximizing the comfort of the surgeon, while providing instruments that enable technically demanding operations, three-dimensional views, and improved dexterity with an internal articulated EndoWrist that allows seven degrees of freedom[14-17].
To date, the most successful application of robotic surgery is robot-assisted radical prostatectomy. Robot-assisted radical prostatectomy was rapidly adopted worldwide. In 2008 in the United States, nearly 80% of radical prostatectomies were performed with robot assistance. More importantly, multiple robot-assisted radical prostatectomy series are now mature enough to demonstrate the safety, efficiency and reproducibility of the procedure, as well as oncologic and functional outcomes comparable to its open counterpart. Robot-assisted surgery is also used in many fields of advanced surgical procedures, such as those for cardiac, gynecologic and pediatric disease. Particularly in cases of complex procedures like mitral valve surgery or surgery in an area that is hard to approach via conventional laparoscopy, a surgical robot is expected to expand the range of minimally invasive surgery (MIS)[19-25].
In the field of general surgery, application of the da Vinci in various gastrointestinal cancers is one of the most important concerns. The purpose of this article is to review the current status of robotic surgery for gastric cancer and submucosal tumors representing gastrointestinal stromal tumor (GIST) and to foresee future prospects.
REPORTS OF APPLICATION IN CLINICAL PRACTICE
Robotic surgery using the da Vinci is a minimally invasive cutting edge surgical technique for treatment of gastric cancer. However, while robot-assisted gastrectomy in the setting of gastric cancer has been reported, only a few reports have examined the technical feasibility. Table 1 summarizes chronologically how robotic surgery has been applied for gastric tumors.
Table 1 Summary of reports on robotic surgery for gastric tumors.
The first robot-assisted gastrectomy was reported by Hashizume et al. in 2003. Since then, a few small series have been reported that show relatively good short-term results comparable to those obtained with laparoscopic or conventional open surgery[27-37]. In 2009, Song et al presented their initial 100 cases of robot-assisted gastrectomy with lymph node dissection; it is the largest series for robotic surgery with gastric cancer in the literature. Then, Hur et al reported total robotic gastrectomy using robot-sewn anastomosis and Ryu et al reported a robot-assisted gastric wedge resection for gastric GIST. These reports appeared to verify the safety and feasibility of this new technology by providing examples of how the robotic surgical system can produce maximum benefits.
The first report on intermediate survival after robot-assisted gastrectomy was recently presented by Pugliese et al. While the number of reports is limited, extra attention is being focused on this new technology and many surgeons are actively trying to perform it for gastric cancer, and the short-term and long-term results will be followed for many years to come.
COMPARISON WITH CONVENTIONAL SURGERY
Feasibility and safety
In general, a longer operation time as well as higher cost and loss of tactile sense are considered to be the disadvantages of robotic surgery in comparison to laparoscopic or open conventional surgery (Table 2). The prolonged operation time is due to the additional time that it takes to set up the robotic arms[16,38-40]. Song et al reported that the docking time initially took about 15 minutes, but that time decreased gradually and reached a plateau after the initial 30 cases. This report on robot-assisted gastrectomy shows that the console time, without additional setting time, was shorter than the total operative time of the initial laparoscopic group and was even similar to the time it took for a recent laparoscopic gastrectomy.
Table 2 Patients’ characteristics and operative outcomes.
aP < 0.05. Lap.: Laparoscopy; BMI: Body mass index.
Robotic assistance provides surgeons with the familiarity of conventional open surgery with its easier maneuverability, allowing MIS to be performed more easily. Thus, in a report comparing the learning curve between conventional laparoscopy and robotic assistance in surgical tasks, laparoscopic surgery showed a steep learning curve, whereas robot-assisted surgery showed better results from the beginning of the initial case with a shallower learning curve, showing the easy adaptability of robot-assisted surgery[31,42-44]. Our unpublished report from a multicenter study also demonstrated that robot-assisted gastrectomy could be rapidly adapted after an initial of around 10 cases by three experienced laparoscopic surgeons.
In conclusion, a robotic surgical system in MIS is a tool that can be used by experienced laparoscopic surgeons to perform robot-assisted surgery, even for initial cases, with a certain level of skill. This report provides good evidence for experienced laparoscopic gastric surgeons who want to start robotic surgery. However, to compare the adaptability of robot-assisted surgery to that of laparoscopic surgery, the results of surgeries performed by a surgeon who had no experience in either field should be compared.
Most studies have reported similar results for post-operative short-term outcomes after robot-assisted gastrectomy compared with laparoscopic surgery (Table 3). Pugliese et al[30,34] showed no differences in time to start mobilization (1.2 d vs 1.2 d, P > 0.05), time to resume diet (4.5 d vs 5 d, P > 0.05) and postoperative hospital stay (10 d vs 10 d, P > 0.05) between the two groups. In contrast, Kim et al, in their comparative study of 16 robotic, 11 laparoscopic, and 12 open gastrectomies, reported a significantly shorter postoperative hospital stay (5.1 d vs 6.5 d vs 6.7 d, P < 0.0001).
Multiple series have reported various ranges in morbidity (5%-46.2%) after robot-assisted gastrectomy, which was not inferior to that of conventional surgery and most cases were wound complications that were minimal without evisceration. Two cases of postoperative mortality were reported but none of these complications were related to the robotic procedure.
ROUTINE D2 LYMPHADENECTOMY AND EXPANSION OF INDICATION IN MIS FOR GASTRIC CANCER
Standard curative surgical treatment for gastric cancer involves radical gastrectomy with lymphadenectomy, nodal clearance is regarded as an especially important factor influencing long-term survival. According to stage-oriented treatment indications by The Japanese Gastric Cancer Association (JGCA), the indication for laparoscopic gastric surgery is limited to the clinical study for Stage IA and Stage IB because there are some limitations to laparoscopic lymphadenectomy compared to conventional open surgery[45,46].
Laparoscopic dissection of the lymph nodes around the superior mesenteric vein (LN 14v), celiac axis (LN 9), and splenic artery (LN 11) is the most frequent source of intraoperative bleeding because of the anatomic complexity of the vascular structures, the limited range of instrument movement, and even for experienced laparoscopic surgeons, unintentional tremor and poor vision[7,43,47,48]. For this reason, laparoscopic gastrectomy was first recommended for only early gastric cancer (EGC) that did not require extensive lymph node dissection because a D1+β dissection with removal of 1 and 3-9 stations according to JGCA is adequate[5,6,11,45,49].
However, some authors assert that D2 dissection should be performed routinely, even in cases diagnosed as EGC from preoperative workup[34,50,51]. Although preoperative staging has become more accurate with the help of recent advances in diagnostic tools, such as endoscopic ultrasonogram, invasiveness through the gastric wall is sometimes underestimated during the preoperative workup[50,52,53]. Pugliese et al reported in their study that preoperative underestimation occurred in 25% of patients diagnosed with mucosal EGC; on histologic examination, 7.5% had advanced gastric cancer (AGC) and 17.5% had submucosal EGC. Therefore, they contend that, until the accuracy of preoperative staging is 100%, routine performance of all gastric cancer surgery with standard D2 dissection remains justified.
Robotics can improve a surgeon’s dexterity and may be especially helpful during maneuvers in restricted fields such as in an extended lymphadenectomy[54-57]. Kim et al, in their comparative study of robotic, laparoscopic, and open gastrectomy, noted no significant differences between the three groups in terms of the number of retrieved lymph nodes (Table 4); this is probably because experienced laparoscopic surgeons can also perform sufficient lymphadenectomy during laparoscopic surgery, similar to open surgery. However, even in this case, the estimated blood loss in the robot-assisted gastrectomy group was significantly less than in other groups. In our unpublished study, we found no significant difference between the number of retrieved lymph nodes in the initial 50 cases of robot-assisted gastrectomy and 85 cases of laparoscopic gastrectomy after the initial learning curve, during the same period, performed by a single surgeon (34.9 vs 34.1, P = 0.733). But, this result is only based on the initial experience; after the accumulation of several cases, robotic surgery is expected to outperform conventional laparoscopic surgery for successful lymph node dissection.
1Values in parentheses are interquartile range. aP < 0.05. Lap.: Laparoscopy; LN: Lymph node.
Robot-assisted gastrectomy with lymphadenectomy for treatment of gastric cancer is safe and can result in good oncologic outcomes, comparable to the results obtained with open surgery, while maintaining the advantages of laparoscopic surgery. Also, robotic surgery is an easy way to expand the indications of MIS to include AGC.
RESPECT OF ONCOLOGIC PRINCIPLES
It is still too early to know for certain the long-term oncologic results of robot-assisted gastrectomy as a treatment for gastric cancer. To date, there is only one published article reporting intermediate survival (Pugliese et al). In that study, 16 patients including EGC and AGC who underwent the robot-assisted gastrectomy, had a mean follow-up of 28 mo (range = 2-44 years). The 3-year overall survival rate was 78% as compared to 85% in the laparoscopic group, but the differences in survival between the two groups were not statistically significant based on the log rank test. Further, there were many limitations in this study, such as non-homogeneous population, small number of series and short follow-up period. It would be more appropriate to wait for long-term oncologic outcomes from large randomized studies.
CHALLENGES IN THE ADVANCED FIELD
Most studies have reported that anastomosis after robot-assisted gastrectomy was performed by extracorporeal hand-sewing sutures or intracorporeal stapler[29,31,32]. The mean body mass index of patients is not high for patients in Eastern countries, because of this extracorporeal anastomosis with a small mini-laparotomy of 4 to 5 cm in length is possible. For the removal of the resected specimen, an incision of at least 3.5 cm is needed, even for Eastern patients. In these cases, extracorporeal anastomosis may be acceptable, considering the technical difficulties and longer operation time required for intracorporeal anastomosis[32,58].
On the other hand, Hur et al presented results of a pilot study in which anastomosis after gastrectomy was successfully achieved by a robot-sewing technique and they showed the possibility of “total” robotic surgery for the treatment of gastric cancer, not just “robot-assisted surgery,” or “robot-assisted laparoscopic surgery”. According to their results, not only anastomosis, such as gastroduodenostomy or gastrojejunostomy, was possible, but also esophagojejunostomy, which should be performed in the deep and narrow space of the abdominal cavity, was feasible, such as urethral anastomosis in radical prostatectomy or valve replacement in cardiac surgery, owing to three-dimensional visualization, wristed instruments with seven degrees of surgical freedom, and tremor filtration[14,17,19-21,59].
This technique seems to maximize the advantage for patients with a high BMI, because the length of mini-laparotomy for extracorporeal anastomosis is not “mini” for obese patients[60-65]. This potential benefit of robotic surgery maintains the merits of laparoscopic surgery compared to open surgery, in terms of postoperative pain and cosmesis[48,49,66]. A recent trend in MIS has been an attempt to reduce the length of skin incision, such as NOTES and single incisional laparoscopic surgery, which is also applicable to robotic surgery.
The advantage of advanced movement using robotic arms in inaccessible areas is also an applicable operative procedure for gastric submucosal tumors (SMTs) including GIST located in difficult positions, especially near the gastroesophageal junction or pylorus, preserving gastric capacity[36,37]. If the issues of high cost and long-term oncologic outcomes are resolved, robot-assisted surgery can be an option for management of patients with gastric SMTs.
Current evidence suggests that the safety and feasibility of robot-assisted gastric surgery has been established. There are still some unresolved issues related to this new technology. First, the appropriateness of surgery in the oncologic perspective should be secured. It is imperative to determine the long-term oncologic outcomes in order to know the exact role of robot-assisted surgery in gastric cancer, especially for application in AGC. Cost-effectiveness is also an important matter. Second, there is the issue of standardization in the training of surgeons with different laparoscopic experience[16,27,40]. The prior results of robot-assisted gastrectomy are derived from studies of experienced laparoscopic surgeons with a certain level of skill. Therefore, a discussion of how to train surgeons without prior laparoscopic experience is needed. Third, appropriated robotic instruments are necessary. The absence of basic devices, such as a suction-irrigator or endostapler, in robotic surgery demands extra ports and the help of an assistant. Through the development of these instruments, the benefits of robotic surgery can be maximized and combined with other fields, such as single incisional laparoscopic surgery, where the use of a robotic system is possible.
Although the current study was limited by its small number of patients and retrospective nature, we found that robot-assisted gastrectomy with lymphadenectomy for the treatment of gastric cancer is technically feasible and safe for experienced laparoscopic surgeons and can produce satisfying postoperative outcomes. Since the oncologic and survival outcomes are the mandatory conclusions in surgical oncology, at least one prospective study comparing open, laparoscopic and robotic gastrectomy and lymphadenectomy is required. Until that time, robot-assisted gastrectomy might be applied very carefully and only in selected patients with Stage Ia and Ib gastric cancer.
Peer reviewers: Yukinori Kurokawa, MD, PhD, Department of Surgery, Osaka National Hospital, 2-1-14, Hoenzaka, Chuo-ku, Osaka 540-0006, Japan; John Griniatsos, MD, Assistant Professor, Department of Surgery, University of Athens, Medical School, 1st LAIKO Hospital, 17 Agiou Thoma str, GR 115-27, Athens, Greece
S- Editor Wang JL L- Editor Hughes D E- Editor Zheng XM
National Institutes of Health Consensus Development Conference Statement on Gallstones and Laparoscopic Cholecystectomy. Am J Surg. 1993;165:390-398.
Kitano S, Shiraishi N, Uyama I, Sugihara K, Tanigawa N. A multicenter study on oncologic outcome of laparoscopic gastrectomy for early cancer in Japan.Ann Surg. 2007;245:68-72.
Huscher CG, Mingoli A, Sgarzini G, Sansonetti A, Di Paola M, Recher A, Ponzano C. Laparoscopic versus open subtotal gastrectomy for distal gastric cancer: five-year results of a randomized prospective trial.Ann Surg. 2005;241:232-237.
Hwang SI, Kim HO, Yoo CH, Shin JH, Son BH. Laparoscopic-assisted distal gastrectomy versus open distal gastrectomy for advanced gastric cancer.Surg Endosc. 2009;23:1252-1258.
Memon MA, Khan S, Yunus RM, Barr R, Memon B. Meta-analysis of laparoscopic and open distal gastrectomy for gastric carcinoma.Surg Endosc. 2008;22:1781-1789.
Kim MC, Kim KH, Kim HH, Jung GJ. Comparison of laparoscopy-assisted by conventional open distal gastrectomy and extraperigastric lymph node dissection in early gastric cancer.J Surg Oncol. 2005;91:90-94.
Shehzad K, Mohiuddin K, Nizami S, Sharma H, Khan IM, Memon B, Memon MA. Current status of minimal access surgery for gastric cancer.Surg Oncol. 2007;16:85-98.
Kim MC, Kim W, Kim HH, Ryu SW, Ryu SY, Song KY, Lee HJ, Cho GS, Han SU, Hyung WJ. Risk factors associated with complication following laparoscopy-assisted gastrectomy for gastric cancer: a large-scale korean multicenter study.Ann Surg Oncol. 2008;15:2692-2700.
Kim W, Song KY, Lee HJ, Han SU, Hyung WJ, Cho GS. The impact of comorbidity on surgical outcomes in laparoscopy-assisted distal gastrectomy: a retrospective analysis of multicenter results.Ann Surg. 2008;248:793-799.
Goh P, Kum CK. Laparoscopic Billroth II gastrectomy: a review.Surg Oncol. 1993;2 Suppl 1:13-18.
Adachi Y, Shiraishi N, Shiromizu A, Bandoh T, Aramaki M, Kitano S. Laparoscopy-assisted Billroth I gastrectomy compared with conventional open gastrectomy.Arch Surg. 2000;135:806-810.
Berguer R. Surgical technology and the ergonomics of laparoscopic instruments.Surg Endosc. 1998;12:458-462.
Dakin GF, Gagner M. Comparison of laparoscopic skills performance between standard instruments and two surgical robotic systems.Surg Endosc. 2003;17:574-579.
Gutt CN, Oniu T, Mehrabi A, Kashfi A, Schemmer P, Büchler MW. Robot-assisted abdominal surgery.Br J Surg. 2004;91:1390-1397.
Patel VR, Chammas MF, Shah S. Robotic assisted laparoscopic radical prostatectomy: a review of the current state of affairs.Int J Clin Pract. 2007;61:309-314.
Giulianotti PC, Coratti A, Angelini M, Sbrana F, Cecconi S, Balestracci T, Caravaglios G. Robotics in general surgery: personal experience in a large community hospital.Arch Surg. 2003;138:777-784.
Lanfranco AR, Castellanos AE, Desai JP, Meyers WC. Robotic surgery: a current perspective.Ann Surg. 2004;239:14-21.
Atug F, Castle EP, Woods M, Davis R, Thomas R. Robotics in urologic surgery: an evolving new technology.Int J Urol. 2006;13:857-863.
Patel VR, Thaly R, Shah K. Robotic radical prostatectomy: outcomes of 500 cases.BJU Int. 2007;99:1109-1112.
Mikhail AA, Orvieto MA, Billatos ES, Zorn KC, Gong EM, Brendler CB, Zagaja GP, Shalhav AL. Robotic-assisted laparoscopic prostatectomy: first 100 patients with one year of follow-up.Urology. 2006;68:1275-1279.
Nifong LW, Chitwood WR, Pappas PS, Smith CR, Argenziano M, Starnes VA, Shah PM. Robotic mitral valve surgery: a United States multicenter trial.J Thorac Cardiovasc Surg. 2005;129:1395-1404.
Tatooles AJ, Pappas PS, Gordon PJ, Slaughter MS. Minimally invasive mitral valve repair using the da Vinci robotic system.Ann Thorac Surg. 2004;77:1978-182; discussion 1978-182;.
Suematsu Y, Kiaii B, Bainbridge DT, del Nido PJ, Novick RJ. Robotic-assisted closure of atrial septal defect under real-time three-dimensional echo guide: in vitro study.Eur J Cardiothorac Surg. 2007;32:573-576.
Smith JM, Stein H, Engel AM, McDonough S, Lonneman L. Totally endoscopic mitral valve repair using a robotic-controlled atrial retractor.Ann Thorac Surg. 2007;84:633-637.
Veljovich DS, Paley PJ, Drescher CW, Everett EN, Shah C, Peters WA. Robotic surgery in gynecologic oncology: program initiation and outcomes after the first year with comparison with laparotomy for endometrial cancer staging.Am J Obstet Gynecol. 2008;198:679.e1-679.9; discussion 679.e1-679.9;.
Hashizume M, Sugimachi K. Robot-assisted gastric surgery.Surg Clin North Am. 2003;83:1429-1444.
Anderson C, Ellenhorn J, Hellan M, Pigazzi A. Pilot series of robot-assisted laparoscopic subtotal gastrectomy with extended lymphadenectomy for gastric cancer.Surg Endosc. 2007;21:1662-1666.
Hyung WJ. [Robotic surgery in gastrointestinal surgery].Korean J Gastroenterol. 2007;50:256-259.
Patriti A, Ceccarelli G, Bellochi R, Bartoli A, Spaziani A, Di Zitti L, Casciola L. Robot-assisted laparoscopic total and partial gastric resection with D2 lymph node dissection for adenocarcinoma.Surg Endosc. 2008;22:2753-2760.
Pugliese R, Maggioni D, Sansonna F, Ferrari GC, Forgione A, Costanzi A, Magistro C, Pauna J, Di Lernia S, Citterio D. Outcomes and survival after laparoscopic gastrectomy for adenocarcinoma. Analysis on 65 patients operated on by conventional or robot-assisted minimal access procedures.Eur J Surg Oncol. 2009;35:281-288.
Song J, Kang WH, Oh SJ, Hyung WJ, Choi SH, Noh SH. Role of robotic gastrectomy using da Vinci system compared with laparoscopic gastrectomy: initial experience of 20 consecutive cases.Surg Endosc. 2009;23:1204-1211.
Song J, Oh SJ, Kang WH, Hyung WJ, Choi SH, Noh SH. Robot-assisted gastrectomy with lymph node dissection for gastric cancer: lessons learned from an initial 100 consecutive procedures.Ann Surg. 2009;249:927-932.
Hur H, Kim JY, Cho YK, Han SU. Technical feasibility of robot-sewn anastomosis in robotic surgery for gastric cancer.J Laparoendosc Adv Surg Tech A. 2010;20:693-697.
Pugliese R, Maggioni D, Sansonna F, Costanzi A, Ferrari GC, Di Lernia S, Magistro C, De Martini P, Pugliese F. Subtotal gastrectomy with D2 dissection by minimally invasive surgery for distal adenocarcinoma of the stomach: results and 5-year survival.Surg Endosc. 2010;24:2594-2602.
Kim MC, Heo GU, Jung GJ. Robotic gastrectomy for gastric cancer: surgical techniques and clinical merits.Surg Endosc. 2010;24:610-615.
Ryu KJ, Jung SR, Choi JS, Jang YJ, Kim JH, Park SS, Park BJ, Park SH, Kim SJ, Mok YJ. Laparoscopic resection of small gastric submucosal tumors.Surg Endosc. 2011;25:271-277.
Buchs NC, Bucher P, Pugin F, Hagen ME, Morel P. Robot-assisted oncologic resection for large gastric gastrointestinal stromal tumor: a preliminary case series.J Laparoendosc Adv Surg Tech A. 2010;20:411-415.
Delaney CP, Lynch AC, Senagore AJ, Fazio VW. Comparison of robotically performed and traditional laparoscopic colorectal surgery.Dis Colon Rectum. 2003;46:1633-1639.
D'Annibale A, Morpurgo E, Fiscon V, Trevisan P, Sovernigo G, Orsini C, Guidolin D. Robotic and laparoscopic surgery for treatment of colorectal diseases.Dis Colon Rectum. 2004;47:2162-2168.
Bodner J, Wykypiel H, Wetscher G, Schmid T. First experiences with the da Vinci operating robot in thoracic surgery.Eur J Cardiothorac Surg. 2004;25:844-851.
Kim MC, Jung GJ, Kim HH. Learning curve of laparoscopy-assisted distal gastrectomy with systemic lymphadenectomy for early gastric cancer.World J Gastroenterol. 2005;11:7508-7511.
Jin SH, Kim DY, Kim H, Jeong IH, Kim MW, Cho YK, Han SU. Multidimensional learning curve in laparoscopy-assisted gastrectomy for early gastric cancer.Surg Endosc. 2007;21:28-33.
Heemskerk J, van Gemert WG, de Vries J, Greve J, Bouvy ND. Learning curves of robot-assisted laparoscopic surgery compared with conventional laparoscopic surgery: an experimental study evaluating skill acquisition of robot-assisted laparoscopic tasks compared with conventional laparoscopic tasks in inexperienced users.Surg Laparosc Endosc Percutan Tech. 2007;17:171-174.
Japanese Gastric Cancer Association. Japanese Classification of Gastric Carcinoma - 2nd English Edition -.Gastric Cancer. 1998;1:10-24.
Nakajima T. Gastric cancer treatment guidelines in Japan.Gastric Cancer. 2002;5:1-5.
Kim MC, Choi HJ, Jung GJ, Kim HH. Techniques and complications of laparoscopy-assisted distal gastrectomy (LADG) for gastric cancer.Eur J Surg Oncol. 2007;33:700-705.
Kim JJ, Song KY, Chin HM, Kim W, Jeon HM, Park CH, Park SM. Totally laparoscopic gastrectomy with various types of intracorporeal anastomosis using laparoscopic linear staplers: preliminary experience.Surg Endosc. 2008;22:436-442.
Uyama I, Sugioka A, Fujita J, Komori Y, Matsui H, Soga R, Wakayama A, Okamoto K, Ohyama A, Hasumi A. Completely laparoscopic extraperigastric lymph node dissection for gastric malignancies located in the middle or lower third of the stomach.Gastric Cancer. 1999;2:186-190.
Shimizu S, Uchiyama A, Mizumoto K, Morisaki T, Nakamura K, Shimura H, Tanaka M. Laparoscopically assisted distal gastrectomy for early gastric cancer: is it superior to open surgery?Surg Endosc. 2000;14:27-31.
Pugliese R, Maggioni D, Sansonna F, Scandroglio I, Ferrari GC, Di Lernia S, Costanzi A, Pauna J, de Martini P. Total and subtotal laparoscopic gastrectomy for adenocarcinoma.Surg Endosc. 2007;21:21-27.
Ganpathi IS, So JB, Ho KY. Endoscopic ultrasonography for gastric cancer: does it influence treatment?Surg Endosc. 2006;20:559-562.
Kitano S, Shiraishi N. Minimally invasive surgery for gastric tumors.Surg Clin North Am. 2005;85:151-64, xi.
Kakeji Y, Konishi K, Ieiri S, Yasunaga T, Nakamoto M, Tanoue K, Baba H, Maehara Y, Hashizume M. Robotic laparoscopic distal gastrectomy: a comparison of the da Vinci and Zeus systems.Int J Med Robot. 2006;2:299-304.
Cadière GB, Himpens J, Germay O, Izizaw R, Degueldre M, Vandromme J, Capelluto E, Bruyns J. Feasibility of robotic laparoscopic surgery: 146 cases.World J Surg. 2001;25:1467-1477.
Shafer A, Boggess JF. Robotic-assisted endometrial cancer staging and radical hysterectomy with the da Vinci surgical system.Gynecol Oncol. 2008;111:S18-S23.
Tewari A, Kaul S, Menon M. Robotic radical prostatectomy: a minimally invasive therapy for prostate cancer.Curr Urol Rep. 2005;6:45-48.
Kojima K, Yamada H, Inokuchi M, Kawano T, Sugihara K. A comparison of Roux-en-Y and Billroth-I reconstruction after laparoscopy-assisted distal gastrectomy.Ann Surg. 2008;247:962-967.
Lee HJ, Kim HH, Kim MC, Ryu SY, Kim W, Song KY, Cho GS, Han SU, Hyung WJ, Ryu SW. The impact of a high body mass index on laparoscopy assisted gastrectomy for gastric cancer.Surg Endosc. 2009;23:2473-2479.
Lee JH, Paik YH, Lee JS, Ryu KW, Kim CG, Park SR, Kim YW, Kook MC, Nam BH, Bae JM. Abdominal shape of gastric cancer patients influences short-term surgical outcomes.Ann Surg Oncol. 2007;14:1288-1294.
Noshiro H, Shimizu S, Nagai E, Ohuchida K, Tanaka M. Laparoscopy-assisted distal gastrectomy for early gastric cancer: is it beneficial for patients of heavier weight?Ann Surg. 2003;238:680-685.
Yasuda K, Inomata M, Shiraishi N, Izumi K, Ishikawa K, Kitano S. Laparoscopy-assisted distal gastrectomy for early gastric cancer in obese and nonobese patients.Surg Endosc. 2004;18:1253-1256.
Kim KH, Kim MC, Jung GJ, Kim HH. The impact of obesity on LADG for early gastric cancer.Gastric Cancer. 2006;9:303-307.
Park DJ, Lee HJ, Kim HH, Yang HK, Lee KU, Choe KJ. Predictors of operative morbidity and mortality in gastric cancer surgery.Br J Surg. 2005;92:1099-1102.
Song KY, Park CH, Kang HC, Kim JJ, Park SM, Jun KH, Chin HM, Hur H. Is totally laparoscopic gastrectomy less invasive than laparoscopy-assisted gastrectomy?: prospective, multicenter study.J Gastrointest Surg. 2008;12:1015-1021.